<DOC>
	<DOCNO>NCT00529867</DOCNO>
	<brief_summary>The purpose study compare safety efficacy child age 6 - 59 month uncomplicated malaria , treat either conventional artemether/lumefantrine tablet ( Coartem® ) artemether/ lumefantrine suspension ( Co-artesiane® ) Western Kenya</brief_summary>
	<brief_title>Randomised Efficacy Study Two Artemether-Lumefantrine Oral Formulations Treatment Uncomplicated P. Falciparum Malaria</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<criteria>Children age 6 59 month Minimum body weight 5kg Presence fever ( Temp &gt; /= 37.5°C ) history fever last 24 hour Presence asexual P. falciparum monoinfection Initial parasite density 2,000 200,000 asexual parasites/µl blood Not suffer severe complicate form malaria Able take drug study oral route Parent guardian give inform write consent participate study Severe and/or complicate malaria ( WHO , 2000 classification ) , include severe anaemia ( Hb =/ &lt; 5 g/dl ) , two seizure last 24 hr hyperparasitaemia ( &gt; 200,000 µl ) Patients treated mefloquine , halofantrine within 7 day Day 0 quinine salt artemisinin derivative within 3 day Day 0 , artemetherlumefantrine 30 day Day 0 Patients require intensive care malaria another severe concomitant illness capable interfere clinical evolution malaria Patients vomit and/or diarrhoea Signs severe malnutrition ( defined follow : child weight/height ratio 3 standard deviation 70 % median WHO standardize reference value , still symmetrical oedema affect foot ) Presence general danger sign child 5 year sign serious complex Plasmodium falciparum , state present WHO definitions Patients know history heart disease arrhythmia History allergy artemether/lumefantrine quinine</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Artemether/Lumefantrine suspension</keyword>
	<keyword>P. falciparum malaria</keyword>
	<keyword>child</keyword>
	<keyword>uncomplicated Plasmodium falciparum malaria</keyword>
</DOC>